Indications O
for O
early O
conversion O
were O
neurotoxicity B
( O
20 O
) O
, O
( B
insulin I
- I
dependent I
) I
diabetes I
mellitus I
( O
IDDM B
) O
( O
5 O
) O
, O
nephrotoxicity B
( O
3 O
) O
, O
gastrointestinal B
( I
GI I
) I
toxicity I
( O
6 O
) O
, O
and O
cardiomyopathy B
( O
1 O
) O
, O
and O
for O
late O
conversion O
were O
neurotoxicity B
( O
15 O
) O
, O
IDDM B
( O
12 O
) O
, O
nephrotoxicity B
( O
3 O
) O
, O
GI B
toxicity I
( O
5 O
) O
, O
hepatotoxicity B
( O
6 O
) O
, O
post B
- I
transplant I
lmphoproliferate I
disease I
( O

Contribution O
of O
sodium O
valproate O
to O
the O
syndrome B
of I
inappropriate I
secretion I
of I
antidiuretic I
hormone I
. O

We O
report O
the O
case O
of O
a O
62 O
- O
year O
- O
old O
man O
who O
was O
administered O
sodium O
valproate O
( O
VPA O
) O
and O
who O
subsequently O
developed O
the O
syndrome B
of I
inappropriate I
secretion I
of I
antidiuretic I
hormone I
( O
SIADH B
) O
. O

BACKGROUND O
: O
Doxorubicin O
induces O
a O
self O
- O
perpetuating O
nephropathy B
characterized O
by O
early O
glomerular B
and I
late I
- I
onset I
tubular I
lesions I
in O
rats O
. O

Hepatitis B
B I
virus I
( I
HBV I
) I
infection I
, O
which O
causes O
liver B
cirrhosis I
and O
hepatocellular B
carcinoma I
, O
remains O
a O
major O
health O
problem O
in O
Asian O
countries O
. O

Urinary O
enzymes O
and O
protein O
patterns O
as O
indicators O
of O
injury B
to I
different I
regions I
of I
the I
kidney I
. O

Myoclonic B
, I
atonic I
, I
and I
absence I
seizures I
following O
institution O
of O
carbamazepine O
therapy O
in O
children O
. O

Clinically O
reversible O
veno B
- I
occlusive I
disease I
of I
the I
liver I
developed O
in O
a O
23 O
- O
year O
- O
old O
man O
with O
acute B
lymphocytic I
leukemia I
after O
10 O
months O
of O
maintenance O
therapy O
with O
6 O
- O
thioguanine O
. O

The O
patient O
, O
a O
69 O
- O
year O
- O
old O
man O
was O
affected O
by O
non B
- I
insulin I
- I
dependent I
diabetes I
mellitus I
and O
hypertension B
. O

We O
conclude O
that O
in O
patients O
with O
chronic O
coronary B
artery I
disease I
who O
are O
not O
in O
clinical O
congestive B
heart I
failure I
left B
ventricular I
end I
- I
diastolic I
volume I
falls I
after O
ouabain O
administration O
even O
when O
it O
is O
initially O
normal O
. O

Left O
carotid O
angiography O
found O
occlusion B
of I
the I
left I
internal I
carotid I
artery I
( O
ICA O
) O
. O

Coexistence O
of O
the O
cerebral B
artery I
and I
the I
venous I
sinus I
occlusion I
has O
been O
described O
infrequently O
. O

